Surgical Indications for Osteoarthritis
Surgery for osteoarthritis, specifically total joint arthroplasty (TJA), is indicated when patients have moderate-to-severe radiographic osteoarthritis (Kellgren-Lawrence grade 3 or 4) with persistent symptomatic burden despite at least 3 months of nonoperative treatment, and once indicated, should proceed directly to surgery without delay for additional conservative therapies. 1, 2
Core Indication Criteria
The surgical threshold requires all of the following elements:
1. Radiographic Evidence
- Kellgren-Lawrence grade 3 or 4 on plain radiographs showing moderate-to-severe joint space narrowing or destruction of most joint space 2, 3
- This is non-negotiable—surgery should not proceed without radiographic confirmation
2. Symptom Burden
The patient must demonstrate:
- Severe pain occurring daily or rest pain several days per week 4
- Transfer pain (pain with standing/sitting transitions) occurring either several days per week for hip or daily for knee 4
- Significant functional limitation affecting daily activities and quality of life 1
3. Failed Conservative Management
- Minimum 3 months of nonoperative treatment including physical therapy, NSAIDs, ambulatory aids, and/or intraarticular injections 2
- Critical point: Once surgery is indicated and conservative therapy has failed, the 2023 ACR/AAHKS guidelines conditionally recommend against delaying surgery for additional nonoperative treatments, as this does not improve outcomes 1
Necessary Preoperative Investigations
Required Studies:
- Plain radiographs (weight-bearing views) to confirm Kellgren-Lawrence grade 3-4 changes
- Hemoglobin A1c if diabetic (to assess glycemic control)
- BMI calculation (document but not a rigid exclusion criterion)
- Nicotine use screening (urine cotinine if indicated)
- Basic metabolic panel and complete blood count
Screening for Modifiable Risk Factors:
- Diabetes status and control 2
- Smoking/nicotine use 2
- Anemia (hemoglobin levels) 2
- Active infection (must be excluded) 2
Timing Algorithm: When to Delay vs. Proceed
Proceed Directly to Surgery (Do NOT Delay):
- Obesity alone (BMI <40 kg/m²)—counsel on increased risk but do not delay for weight loss targets 1
- Severe deformity or bone loss—proceed without delay 1
- Neuropathic joint—proceed without delay 1
- After failed conservative therapy—no additional delay for more PT, injections, or NSAIDs 1
Conditionally Delay Surgery For:
- Active nicotine use: Delay for cessation or reduction 1
- Uncontrolled diabetes: Delay for improved glycemic control (though no specific HbA1c threshold identified in guidelines) 1
- BMI ≥40 kg/m²: This represents an absolute threshold where optimization is recommended 2
- Active infection: Absolute contraindication until resolved 2
- Severe anemia: Optimize before proceeding 2
Risk Stratification from Evidence
Factors Associated with Worse Outcomes (Counsel but Generally Don't Exclude):
- Obesity: Strong evidence shows obese patients have less improvement in outcomes but still benefit from TKA 3
- Diabetes: Moderate evidence shows higher complication risk 3
- Chronic pain conditions: Moderate evidence shows less improvement in patient-reported outcomes 3
- Depression/anxiety: Limited evidence shows less improvement in outcomes 3
Critical Pitfalls to Avoid
Do not delay surgery indefinitely pursuing rigid BMI thresholds below 40 kg/m²—this is not supported by evidence and denies patients effective treatment 1
Do not require additional months of physical therapy or injections once surgical criteria are met and conservative therapy has failed for 3 months—this delays definitive treatment without benefit 1
Do not use arthroscopy as a temporizing measure or treatment for OA—it does not alter disease progression and is not recommended 5
Do not proceed with surgery in patients with BMI ≥40 kg/m² without optimization, or with active infection 2
Recognize that "end-stage OA" is often misused—patients can still improve with non-surgical treatment even with severe radiographic changes, and the term should be replaced with "surgical threshold" to better reflect clinical reality 6
Shared Decision-Making Framework
After meeting objective criteria, engage in shared decision-making that addresses:
- Individual patient's unique risks based on comorbidities
- Realistic expectations about pain relief (typically excellent) and functional improvement
- Prosthesis lifespan considerations (especially in younger patients)
- Patient's desire for independence and return to activities 1, 4
The evidence quality for all timing recommendations is low to very low 1, but the consensus among expert panels is high, and TJA remains the gold standard for severe symptomatic OA with proven cost-effectiveness and substantial quality of life improvements 5.